Sri Lanka vs Tunisia: HIV/AIDS deaths averted by antiretroviral therapy
Sri Lanka
217.06 deaths
in 2024
Tunisia
198.78 deaths
in 2024
Sri Lanka rank
109th
Tunisia rank
110th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Sri Lanka
- Tunisia
How they compare
Sri Lanka currently reports 217.06 deaths against 198.78 deaths in Tunisia, a difference of 18.28 deaths.
That makes Sri Lanka's figure about 1.1 times Tunisia's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Tunisia ahead.
Sri Lanka ranks 109th and Tunisia ranks 110th of 157 countries.
Across the 4 decades both report, Sri Lanka averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Sri Lanka | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 11.47 deaths | 23.7 deaths | 12.23 deaths | Tunisia |
| 2010s | 86.12 deaths | 81.37 deaths | 4.75 deaths | Sri Lanka |
| 2020s | 187.06 deaths | 164.95 deaths | 22.11 deaths | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Sri Lanka or Tunisia?
- Sri Lanka, at 217.06 deaths against 198.78 deaths in Tunisia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Sri Lanka and Tunisia?
- 18.28 deaths, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Tunisia?
- 35 years are reported by both, from 1990 to 2024.
- How do Sri Lanka and Tunisia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Sri Lanka ranks 109th and Tunisia ranks 110th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.